1. Chen, Yan, Zhang, Xiaowei, Zhang, Mingcheng, Lin, Yueyue, Li, Guodong. 2024. UTP11 promotes the growth of hepatocellular carcinoma by enhancing the mRNA stability of Oct4. In BMC cancer, 24, 93. doi:10.1186/s12885-023-11794-2. https://pubmed.ncbi.nlm.nih.gov/38233795/
2. Shi, Laner, Shang, Xin, Nie, Kechao, Yuan, Haoyu, Zhu, Zhangzhi. 2020. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma. In Journal of clinical pathology, 74, 504-512. doi:10.1136/jclinpath-2020-206979. https://pubmed.ncbi.nlm.nih.gov/33004423/
3. Yang, Luqun, Guan, Xin, Cheng, Jiangwei, Li, Bingjie, Lin, Yuanyuan. 2025. VAMP8 as a biomarker and potential therapeutic target for endothelial cell dysfunction in atherosclerosis. In Gene, 942, 149231. doi:10.1016/j.gene.2025.149231. https://pubmed.ncbi.nlm.nih.gov/39800194/
4. Wei, Shuxu, Shen, Ronghuai, Lu, Xiaojia, Shu, Zhouwu, Huang, Xianxi. 2025. Mendelian randomization provides a multi-omics perspective on the regulation of genes involved in ribosome biogenesis in relation to cardiac structure and function. In Clinical epigenetics, 17, 42. doi:10.1186/s13148-025-01850-y. https://pubmed.ncbi.nlm.nih.gov/40045424/